Osaic Holdings
NYMX

Osaic Holdings’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Osaic Holdings’s Portfolio NYMX Stock Details NYMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-20,400
Closed -$3.88K – 7692
2023
Q2 		$3.88K Hold
20,400
– – ﹤0.01% 6422
2023
Q1 		$6.94K Hold
20,400
– – ﹤0.01% 6185
2022
Q4 		$7K Buy
20,400
+12,400
+155% +$4.49K ﹤0.01% 6161
2022
Q3 		$3K Hold
8,000
– – ﹤0.01% 6707
2022
Q2 		$3K Hold
8,000
– – ﹤0.01% 6802
2022
Q1 		$10K Hold
8,000
– – ﹤0.01% 6165
2021
Q4 		$10K Sell
8,000
-4,100
-34% -$6.54K ﹤0.01% 6288
2021
Q3 		$25K Buy
12,100
+9,500
+365% +$16.8K ﹤0.01% 5629
2021
Q2 		$4K Hold
2,600
– – ﹤0.01% 6537
2021
Q1 		$6K Sell
2,600
-1,600
-38% -$4.22K ﹤0.01% 6110
2020
Q4 		$10K Sell
4,200
-800
-16% -$1.77K ﹤0.01% 5534
2020
Q3 		$12K Sell
5,000
-6,900
-58% -$20.1K ﹤0.01% 5198
2020
Q2 		$42K Buy
11,900
+6,900
+138% +$21.8K ﹤0.01% 4317
2020
Q1 		$12K Buy
+5,000
New +$14K ﹤0.01% 4920

Other funds holding NYMX

DDC
DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return
FCFC
First Citizens Financial Corp Mason City, Iowa $239M AUM 26.56% 1-Year Est. Return
CAM
Cubic Asset Management Boston, Massachusetts $422M AUM 29.18% 1-Year Est. Return
ODIJL
One Day In July LLC Burlington, Vermont $1.25B AUM 12.08% 1-Year Est. Return

Osaic Holdings's NYMX Position: Q3 2023 in Review

Osaic Holdings sold out of Nymox Pharmaceutical Corp (NYMX) in Q3 2023, closing a stake of 20,400 shares — an estimated $3.88K sold.

Osaic Holdings first reported a position in NYMX in Q1 2020 and held it in 14 quarters. The position peaked at $42K in Q2 2020. 5 funds tracked by Wall St. Rank hold NYMX as of Q3 2023.

  • Osaic Holdings reported no remaining Nymox Pharmaceutical Corp position as of Q3 2023 after selling out during the quarter.
  • Osaic Holdings sold 20,400 Nymox Pharmaceutical Corp shares in Q3 2023, an estimated $3.88K.
  • Osaic Holdings first reported a position in Nymox Pharmaceutical Corp in Q1 2020 and held it in 14 quarters.
  • Osaic Holdings's Nymox Pharmaceutical Corp position peaked at $42K in Q2 2020.
  • 5 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q3 2023.

Based on Osaic Holdings's 13F filing for Q3 2023, filed 13 Nov 2023.